4//SEC Filing
Taylor Andrew Lawrence 4
Accession 0001104659-25-032330
CIK 0001814114other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 9:37 PM ET
Size
5.4 KB
Accession
0001104659-25-032330
Insider Transaction Report
Form 4
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.0001 per share ("Common Stock")
2025-04-04+84,000→ 428,960 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after April 4, 2025 (the "Issue Date"), (ii) 33.33% of the shares will vest 30 months after the Issue Date, and (iii) 33.34% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001723889
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 9:37 PM ET
- Size
- 5.4 KB